No abstract available
MeSH terms
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / pharmacology
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antirheumatic Agents / pharmacology*
-
Antirheumatic Agents / therapeutic use*
-
Humans
-
Interleukin-12 / antagonists & inhibitors
-
Interleukin-12 / physiology
-
Interleukin-17 / antagonists & inhibitors
-
Interleukin-17 / physiology
-
Interleukin-6 / antagonists & inhibitors
-
Interleukin-6 / physiology
-
Signal Transduction / drug effects*
-
Signal Transduction / physiology
-
Spondylitis, Ankylosing / drug therapy*
-
Spondylitis, Ankylosing / physiopathology
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
Ustekinumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Interleukin-17
-
Interleukin-6
-
Tumor Necrosis Factor-alpha
-
Interleukin-12
-
secukinumab
-
Ustekinumab
-
tocilizumab